Atlas Trials

Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder

Clinical trial NCT03434366 · SUSPENDED

Trial details

NCT number
NCT03434366
Sponsor
Guangzhou Women and Children's Medical Center
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2018-01-20
Primary completion
2023-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.